Protective effects of dendrosomal curcumin on an animal metastatic breast tumor

European Journal of Pharmacology

Volumn 758, Issue , 2015, Pages 188-196

  Farhangi, Baharak ^a   Alizadeh, Ali Mohammad ^a   Khodayari, Hamid ^a   Khodayari, Saeed ^a   Dehghan, Mohammad Javad ^b   Khori, Vahid ^c   Heidarzadeh, Alemeh ^b   Khaniki, Mahmood ^a   Sadeghiezadeh, Majid ^b   Najafi, Farhood ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE FOR COLOR SCIENCE AND TECHNOLOGY   (Iran)

Author keywords

Breast cancer; Dendrosomal curcumin; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DENDRIMER;

ANIMAL; CELL ADHESION; CELL LINE; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; MOUSE; SYNTHESIS; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CURCUMIN; DENDRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; TUMOR BURDEN;

EID: 84930786554     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.076     Document Type: Article

References (46)

1. B.B. Aggarwal Nuclear factor-kappaB: the enemy within Cancer Cell 6 3 2004 203 208
2. B.B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R.A. Newman, C.E. Bueso-Ramos, and J.E. Price Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin. Cancer Res. 11 20 2005 7490 7498
3. Aggarwal, B.B., Surh, Y.-J., Shishodia, S., 2007. Springer Link (Online service). The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Advances in Experimental Medicine and Biology, vol. 595. Springer, New York, NY, xxi, 489 p. ill. 425 cm
4. A.M. Alizadeh, M. Khaniki, S. Azizian, M.A. Mohaghgheghi, M. Sadeghizadeh, and F. Najafi Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin Eur. J. Pharmacol. 689 1 2012 226 232
5. A.M. Alizadeh, M. Sadeghizadeh, F. Najafi, S.K. Ardestani, V. Erfani-Moghadam, M. Khaniki, A. Rezaei, M. Zamani, S. Khodayari, H. Khodayari, and M.A. Mohagheghi Encapsulation of curcumin in diblock copolymer micelles for cancer therapy Biomed. Res. Int. 2015 2015 824746
6. A.M. Alizadeh, S. Shiri, and S. Farsinejad Metastasis review: from bench to bedside Tumor Biol. 35 9 2014 8483 8523
7. E. Babaei, M. Sadeghizadeh, Z.M. Hassan, M.A.H. Feizi, F. Najafi, and S.M. Hashemi Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo Int. Immunopharmacol. 12 1 2012 226 234
8. B.E. Bachmeier, A.G. Nerlich, C.M. Iancu, M. Cilli, E. Schleicher, R. Vene, R. Dell'Eva, M. Jochum, A. Albini, and U. Pfeffer The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice Cell. Physiol. Biochem. 19 1-4 2007 137 152
9. M. Bayet-Robert, F. Kwiatowski, M. Leheurteur, F. Gachon, E. Planchat, C. Abrial, M.-A. Mouret-Reynier, X. Durando, C. Barthomeuf, and P. Chollet Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer Cancer Biol. Ther. 9 1 2010 8 14
10. A.C. Bharti, and B.B. Aggarwal Nuclear factor-kappa B and cancer: its role in prevention and therapy Bioch. Pharmacol. 64 5 2002 883 888
11. P. Carmeliet VEGF as a key mediator of angiogenesis in cancer Oncology 69 2004 4 10
12. T.-L. Chiu, and C.-C. Su Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-κBp65 expression in breast cancer MDA-MB-231 cells Int. J. Mol. Med. 23 4 2009 469 475
13. M. Dastpeyman, N. Motamed, K. Azadmanesh, E. Mostafavi, V. Kia, A. Jahanian-Najafabadi, and M.A. Shokrgozar Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI Med. Oncol. 29 4 2012 2512 2518
14. A.R. Farina, A. Tacconelli, A. Vacca, M. Maroder, A. Gulino, and A.R. Mackay Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements Cell Growth Differ. 10 1999 353 367
15. N. Ferrara Molecular and biological properties of vascular endothelial growth factor J. Mol. Med. 77 7 1999 527 543
16. G. Gasparini, R. Longo, M. Toi, and N. Ferrara Angiogenic inhibitors: a new therapeutic strategy in oncology Nat. Clin. Pract. Oncol. 2 11 2005 562 577
17. N. Ghalandarlaki, A.M. Alizadeh, and S. AshkaniEsfahani Nanotechnology-applied curcumin for different diseases therapy Biomed. Res. Int. 2014 2014 394264
18. A. Gómez-Hernández, J.L. Martín-Ventura, E. Sánchez-Galán, C. Vidal, M. Ortego, L.M. Blanco-Colio, L. Ortega, J. Tuñón, and J. Egido Overexpression of COX-2, prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-κB Atherosclerosis 187 1 2006 139 149
19. S.C. Gupta, S. Patchva, and B.B. Aggarwal Therapeutic roles of curcumin: lessons learned from clinical trials AAPS J. 15 1 2013 195 218
20. B. Himelstein, R. Canete-Soler, E. Bernhard, D. Dilks, and R. Muschel Metalloproteinases in tumor progression: the contribution of MMP-9 Invasion Metastasis 14 1-6 1993 246 258
21. J. Hong, S. Sang, H.-J. Park, S.J. Kwon, N. Suh, M.-T. Huang, C.-T. Ho, and C.S. Yang Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives Carcinogenesis 27 2 2006 278 286
22. M.A. Huber, N. Azoitei, B. Baumann, S. Grünert, A. Sommer, H. Pehamberger, N. Kraut, H. Beug, and T. Wirth NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J. Clin. Investig. 114 4 2004 569
23. H. Huei-Chen, J. Tong-Rong, and Y. Sheau-Farn Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation Eur. J. Pharmacol. 221 2 1992 381 384
24. H. Im Kim, H. Huang, S. Cheepala, S. Huang, and J. Chung Curcumin inhibition of integrin (α6β4)-dependent breast cancer cell motility and invasion Cancer Prev. Res. 1 5 2008 385 391
25. H.J. Kang, S.H. Lee, J.E. Price, and L.S. Kim Curcumin suppresses the paclitaxel-induced nuclear factor-κb in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model Breast J. 15 3 2009 223 229
26. S. Kardeh, S. Ashkani-Esfahani, and A.M. Alizadeh Paradoxical action of reactive oxygen species in creation and therapy of cancer Eur. J. Pharmacol. 735 2014 150 168
27. G.J. Kelloff, J.A. Crowell, V.E. Steele, R.A. Lubet, W.A. Malone, C.W. Boone, L. Kopelovich, E.T. Hawk, R. Lieberman, and J.A. Lawrence Progress in cancer chemoprevention: development of diet-derived chemopreventive agents J. Nutr. 130 2 2000 467S 471S
28. N. Khan, and H. Mukhtar Cancer and metastasis: prevention and treatment by green tea Cancer Metastasis Rev. 29 3 2010 435 445
29. M. Khaniki, S. Azizian, A.M. Alizadeh, H. Hemmati, N. Emamipour, and M.A. Mohagheghi The antiproliferative and anticancerogenic effects of nano-curcumin in rat colon cancer Tehran Univ. Med. J. 71 5 2013 277 284
30. P.H. Killian, E. Kronski, K.M. Michalik, O. Barbieri, S. Astigiano, C.P. Sommerhoff, U. Pfeffer, A.G. Nerlich, and B.E. Bachmeier Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2 Carcinogenesis 33 12 2012 2507 2519
31. M. Kitamura, T. Sütö, T. Yokoo, F. Shimizu, and L.G. Fine Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156 8 1996 2964 2971
32. F. Kiuchi, Y. Goto, N. Sugimoto, N. Akao, K. Kondo, and Y. Tsuda Nematocidal activity of turmeric: synergistic action of curcuminoids Chem. Pharm. Bull. 41 9 1993 1640
33. M. Koide, Y. Murase, K. Yamato, T. Noguchi, N. Okahashi, and T. Nishihara Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1α through upregulation of osteoclast differentiation factor and cyclooxygenase-2 Biochem. Biophys. Res. Commun. 259 1 1999 97 102
34. E. Kronski, M.E. Fiori, O. Barbieri, S. Astigiano, V. Mirisola, P.H. Killian, A. Bruno, A. Pagani, F. Rovera, and U. Pfeffer miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2 Mol. Oncol. 8 3 2014 581 595
35. J.-L. Luo, H. Kamata, and M. Karin IKK/NF-κB signaling: balancing life and death-a new approach to cancer therapy J. Clin. Investig. 115 10 2005 2625
36. M.T. Mirgani, B. Isacchi, M. Sadeghizadeh, F. Marra, A.R. Bilia, S.J. Mowla, F. Najafi, and E. Babaei Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells Int. J. Nanomed. 9 2014 403
37. M. Mohsenikia, A.M. Alizadeh, S. Khodayari, H. Khodayari, A. Karimi, M. Zamani, S. Azizian, and M.A. Mohagheghi The protective and therapeutic effects of alpha-solanine on mice breast cancer Eur. J. Pharmacol. 718 1 2013 1 9
38. M.J. Oudhoff, J.G. Bolscher, K. Nazmi, H. Kalay, W. van't Hof, A.V.N. Amerongen, and E.C. Veerman Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay FASEB J. 22 11 2008 3805 3812
39. M.C. Perry, M. Demeule, A. Régina, R. Moumdjian, and R. Béliveau Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts Mol. Nutr. Food Res. 54 8 2010 1192 1201
40. S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, S. Farrow, and L. Howells Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kB activation via the NIK/IKK signalling complex Oncogene 18 44 1999 6013 6020
41. M.N. Sarbolouki, A.M. Alizadeh, M. Khaniki, S. Azizian, and M.A. Mohaghgheghi Protective effect of dendrosomal curcumin combination on colon cancer in rat Tehran Univ. Med. Sci. 69 11 2012
42. M.N. Sarbolouki, M. Sadeghizadeh, M.M. Yaghoobi, A. Karami, and T. Lohrasbi Dendrosomes: a novel family of vehicles for transfection and therapy J. Chem. Technol. Biotechnol. 75 10 2000 919 922
43. M. Shiraga, S. Yano, A. Yamamoto, H. Ogawa, H. Goto, T. Miki, K. Miki, H. Zhang, and S. Sone Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines Cancer Res. 62 20 2002 5967 5973
44. S. Shishodia, H.M. Amin, R. Lai, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem. Pharmacol. 70 5 2005 700 713
45. D. Wang, M.S. Veena, K. Stevenson, C. Tang, B. Ho, J.D. Suh, V.M. Duarte, K.F. Faull, K. Mehta, and E.S. Srivatsan Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway Clin. Cancer Res. 14 19 2008 6228 6236
46. T.-X. Xie, Z. Xia, N. Zhang, W. Gong, and S. Huang Constitutive NF-κB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma Oncol. Rep. 23 3 2010 725 732